JPRN-UMIN000039598已完成未知
Effect of roxadustat on renal anemia in hemodialysis patients - Effect of roxadustat on renal anemia
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 18
研究概览
简要总结
Roxadustat (median 100 mg/HD) could maintain Hb in dialysis patients treated with high-dose darbepoetin (mean dose 54 maicrogram/wk) for 1 year.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients complicated with serious diseases such as malignancy, heart failure (NYHA III degrees or more), and liver cirrhosis
研究者
相似试验
招募中
Unknown
Renal Anemia Treatment with Roxadustat for Non-dialysis Patients with Lower Extremity Artery Disease: The REFINE trialJPRN-jRCTs031230506eki Yasushi100
已完成
2 期
Effect of Roxadustat in management of anemia and iron regulation in cirrhosis of liver patientsCirrhosis of liver patients who is anemicAnemia, Cirrhosis of Liver, Treatment with Roxadustat a hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitorTCTR20230615001Bangabandhu Sheikh Mujib Medical University75
已完成
不适用
Effect of daprodustat on renal anemia in patients with chronic kidney diseasechronic kidney diseaseJPRN-UMIN000041546Saitama Tsukinomori Clinic10
尚未招募
2 期
The Effect of Roxadustat on Renal Oxygenation in Diabetes NephropathyDiabetes ComplicationsDiabetes; Nephropathy (Manifestation)NCT05810311Region Stockholm30
已完成
不适用
Effect of roxadustat on erythropoiesis and iron metabolismJPRN-UMIN000045857Showa University34